Jump Financial, LLC Y M Abs Therapeutics, Inc. Transaction History
Jump Financial, LLC
- $6.93 Billion
- Q1 2025
A detailed history of Jump Financial, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 38,079 shares of YMAB stock, worth $146,984. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,079
Previous 33,380
14.08%
Holding current value
$146,984
Previous $261,000
35.63%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding YMAB
# of Institutions
106Shares Held
27.2MCall Options Held
38.4KPut Options Held
2.1K-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$16.4 Million0.96% of portfolio
-
Acorn Capital Advisors, LLC New York, NY3.24MShares$12.5 Million9.97% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$11.3 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$8.47 Million0.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$7.51 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $169M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...